Wells Fargo notes that Clinicaltrials.gov lists Penumbra’s THUNDER trial as having reduced the total enrollment number to 216 from 275 as of October 16, so when Penumbra announc ...
2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients with acute ischemic ...